Cargando…

Adenoid cystic carcinoma: emerging role of translocations and gene fusions

Adenoid cystic carcinoma (ACC), the second most common salivary gland malignancy, is notorious for poor prognosis, which reflects the propensity of ACC to progress to clinically advanced metastatic disease. Due to high long-term mortality and lack of effective systemic treatment, the slow-growing bu...

Descripción completa

Detalles Bibliográficos
Autores principales: Wysocki, Piotr T., Izumchenko, Evgeny, Meir, Juliet, Ha, Patrick K., Sidransky, David, Brait, Mariana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5323230/
https://www.ncbi.nlm.nih.gov/pubmed/27533466
http://dx.doi.org/10.18632/oncotarget.11288
_version_ 1782509995884019712
author Wysocki, Piotr T.
Izumchenko, Evgeny
Meir, Juliet
Ha, Patrick K.
Sidransky, David
Brait, Mariana
author_facet Wysocki, Piotr T.
Izumchenko, Evgeny
Meir, Juliet
Ha, Patrick K.
Sidransky, David
Brait, Mariana
author_sort Wysocki, Piotr T.
collection PubMed
description Adenoid cystic carcinoma (ACC), the second most common salivary gland malignancy, is notorious for poor prognosis, which reflects the propensity of ACC to progress to clinically advanced metastatic disease. Due to high long-term mortality and lack of effective systemic treatment, the slow-growing but aggressive ACC poses a particular challenge in head and neck oncology. Despite the advancements in cancer genomics, up until recently relatively few genetic alterations critical to the ACC development have been recognized. Although the specific chromosomal translocations resulting in MYB-NFIB fusions provide insight into the ACC pathogenesis and represent attractive diagnostic and therapeutic targets, their clinical significance is unclear, and a substantial subset of ACCs do not harbor the MYB-NFIB translocation. Strategies based on detection of newly described genetic events (such as MYB activating super-enhancer translocations and alterations affecting another member of MYB transcription factor family-MYBL1) offer new hope for improved risk assessment, therapeutic intervention and tumor surveillance. However, the impact of these approaches is still limited by an incomplete understanding of the ACC biology, and the manner by which these alterations initiate and drive ACC remains to be delineated. This manuscript summarizes the current status of gene fusions and other driver genetic alterations in ACC pathogenesis and discusses new therapeutic strategies stemming from the current research.
format Online
Article
Text
id pubmed-5323230
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-53232302017-03-23 Adenoid cystic carcinoma: emerging role of translocations and gene fusions Wysocki, Piotr T. Izumchenko, Evgeny Meir, Juliet Ha, Patrick K. Sidransky, David Brait, Mariana Oncotarget Review Adenoid cystic carcinoma (ACC), the second most common salivary gland malignancy, is notorious for poor prognosis, which reflects the propensity of ACC to progress to clinically advanced metastatic disease. Due to high long-term mortality and lack of effective systemic treatment, the slow-growing but aggressive ACC poses a particular challenge in head and neck oncology. Despite the advancements in cancer genomics, up until recently relatively few genetic alterations critical to the ACC development have been recognized. Although the specific chromosomal translocations resulting in MYB-NFIB fusions provide insight into the ACC pathogenesis and represent attractive diagnostic and therapeutic targets, their clinical significance is unclear, and a substantial subset of ACCs do not harbor the MYB-NFIB translocation. Strategies based on detection of newly described genetic events (such as MYB activating super-enhancer translocations and alterations affecting another member of MYB transcription factor family-MYBL1) offer new hope for improved risk assessment, therapeutic intervention and tumor surveillance. However, the impact of these approaches is still limited by an incomplete understanding of the ACC biology, and the manner by which these alterations initiate and drive ACC remains to be delineated. This manuscript summarizes the current status of gene fusions and other driver genetic alterations in ACC pathogenesis and discusses new therapeutic strategies stemming from the current research. Impact Journals LLC 2016-08-14 /pmc/articles/PMC5323230/ /pubmed/27533466 http://dx.doi.org/10.18632/oncotarget.11288 Text en Copyright: © 2016 Wysocki et al. http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Review
Wysocki, Piotr T.
Izumchenko, Evgeny
Meir, Juliet
Ha, Patrick K.
Sidransky, David
Brait, Mariana
Adenoid cystic carcinoma: emerging role of translocations and gene fusions
title Adenoid cystic carcinoma: emerging role of translocations and gene fusions
title_full Adenoid cystic carcinoma: emerging role of translocations and gene fusions
title_fullStr Adenoid cystic carcinoma: emerging role of translocations and gene fusions
title_full_unstemmed Adenoid cystic carcinoma: emerging role of translocations and gene fusions
title_short Adenoid cystic carcinoma: emerging role of translocations and gene fusions
title_sort adenoid cystic carcinoma: emerging role of translocations and gene fusions
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5323230/
https://www.ncbi.nlm.nih.gov/pubmed/27533466
http://dx.doi.org/10.18632/oncotarget.11288
work_keys_str_mv AT wysockipiotrt adenoidcysticcarcinomaemergingroleoftranslocationsandgenefusions
AT izumchenkoevgeny adenoidcysticcarcinomaemergingroleoftranslocationsandgenefusions
AT meirjuliet adenoidcysticcarcinomaemergingroleoftranslocationsandgenefusions
AT hapatrickk adenoidcysticcarcinomaemergingroleoftranslocationsandgenefusions
AT sidranskydavid adenoidcysticcarcinomaemergingroleoftranslocationsandgenefusions
AT braitmariana adenoidcysticcarcinomaemergingroleoftranslocationsandgenefusions